INTRODUCTION
The continuous production of blood and immune cells is regulated by a small number of multipotent and self-renewing hematopoietic stem cells (HSCs) residing in the bone marrow of adult mammals (Orkin and Zon, 2008) . In response to bone marrow injury or infection, long-term quiescent HSCs are efficiently recruited into the cell cycle and return back to quiescence after re-establishment of homeostasis (Baldridge et al., 2010; Essers et al., 2009; Wilson et al., 2008) . Positioned at the apex of the hierarchically organized hematopoietic system, HSCs generate a series of progenitor cells that undergo several consecutive commitment steps, becoming progressively restricted in their lineage potential and finally producing unipotent progenitors (Orkin and Zon, 2008) . Megakaryocytes (Mks) are large, polyploid cells that release platelets into the circulation (Machlus and Italiano, 2013) . According to the classical model of hematopoiesis, each mature Mk derives from an HSC that sequentially transitioned through the multipotent progenitor (MPP), common myeloid progenitor (CMP), Mk-erythroid progenitor (MEP), and Mk progenitor (MkP) states, followed by endomitosis to generate a mature Mk (Machlus and Italiano, 2013) . However, the first evidence for a potential bypass of some intermediate states from HSCs toward Mks was provided when transcriptional profiling revealed expression of Mk transcripts in highly purified HSCs (Må nsson et al., 2007) . More recently, mRNA expression of the Mk marker von Willebrand factor (Vwf) and the surface receptor c-Kit were suggested to be indicative of a platelet-biased, but multipotent HSC sub-population (Sanjuan-Pla et al., 2013; Shin et al., 2014) . Moreover, the existence of Mk-lineage restricted cells with high self-renewal activity in the phenotypic HSC compartment was proposed based on single-cell transplantation experiments (Yamamoto et al., 2013) . However, a molecular and cellular characterization of these potent Mk-restricted cells is lacking and the purpose of Mk-lineage priming effects and potential physiological benefits of shortcuts into the Mk lineage remain unclear.
Recent reports highlight the importance of platelets as inflammatory and immune cells in addition to their well-known function in thrombosis (Semple et al., 2011; Yeaman, 2014) . Systemic inflammation associated with acute infections triggers the release of immunomodulatory agents and the interaction of platelets with neutrophils to facilitate the formation of neutrophil extracellular traps (NETs) (Jenne et al., 2013; Yeaman, 2014) . This provokes a rapid consumption of platelets, resulting in a transient thrombocytopenia (Stohlawetz et al., 1999; TacchiniCottier et al., 1998) . During acute inflammation, low platelet levels are associated with a loss of vascular integrity and hemorrhage, as well as septic shock, resulting in increased mortality (Goerge et al., 2008; Xiang et al., 2013) . Therefore, a fast recovery of platelet levels is essential. However, the exact mechanism by which platelet levels are rapidly regenerated after acute inflammation remains unknown.
Here, we report the existence of potent stem-like Mkcommitted progenitors (SL-MkPs) within the phenotypic HSC compartment. Under stress conditions like viral infections, acute inflammatory signaling triggers cell cycle activation of quiescent SL-MkPs and Mk protein production, which drives a rapid maturation program of SL-MkPs and other MkPs. Together, this mediates an efficient platelet recovery after inflammation-induced thrombocytopenia.
RESULTS

Inflammatory Signaling Drives Megakaryocytic Protein Expression in Phenotypic HSCs
Inflammatory signaling during infection triggers a rapid depletion of circulating platelets and other blood cells. To study the hematopoietic system during such stress conditions, we mimicked a viral infection by inducing acute inflammation through administration of a single dose of polyinosinic:polycytidylic acid (pI:C) to mice. As expected, inflammation was associated with dramatic reduction in platelet numbers, but homeostatic blood platelet levels were restored within a few days, suggesting intensive platelet regeneration ( Figure 1A ). To elucidate which cell types might be involved in this rapid platelet regeneration program, we measured the expression of CD41 (Itga2b), an early marker of megakaryocytic maturation, in distinct cell populations of the hematopoietic stem and progenitor cell compartment during homeostasis and 16 hr after pI:C induction (see Supplemental Information; Figures S1A-S1C for gating strategies under inflammation). In accordance with previous reports, CD41 was expressed in MkPs and at low levels in a subset of HSCs during homeostasis (Gekas and Graf, 2013) . Unexpectedly, all investigated cell types potentially capable of generating Mks robustly increased CD41 protein expression upon pI:C treatment, including MkPs, MEPs, and, most surprisingly, phenotypic HSCs, whereas other cell types remained unaffected ( Figure 1B ). Since inflammation induced the strongest relative upregulation of CD41 in the HSC compartment, we subjected fluorescence activated cell sorting (FACS) + CD48 + ) from control and pI:C treated mice to mass spectrometry-based quantitative proteomics in order to globally characterize inflammation-mediated changes in the HSC proteome. Of a total of 7,492 identified proteins, 162 proteins were significantly changed in HSCs upon induction of inflammation (Table  S1 ). As expected, pI:C treatment triggered the production of typical interferon (IFN) response proteins ( Figures 1C, 1D , S1D, and S1E), but also revealed a significant increase of 28 proteins typically expressed in mature Mks and platelets (Figures 1C, 1D, and S1E) . These included CD41 (Itga2b) and its partner CD61 (Itgb3), components of the GPIb-IX-V complex, platelet-selectin (Selp), the platelet and Mk-specific b1 tubulin (Tubb1), as well as many proteins characteristic for Mk and platelet alpha-granules, such as Vwf and platelet factor 4 (Pf4).
In concert with our finding that inflammation-driven Mk protein increase is highest in HSCs ( Figure 1B ), the upregulation of Mk proteins in Lin À cKit + CD150 + CD48 + progenitors was almost absent ( Figures 1C, 1D , S1E, and S1F).
Since pI:C administration triggers a wide production and secretion of type-I IFNs in vivo, we hypothesized that type-I IFN signaling might be involved in regulating the production of Mk proteins in HSCs. Accordingly, administration of recombinant IFNa phenocopied pI:C injections with regards to Mk protein upregulation ( Figure S1G ), and the pI:C-mediated increase in Mk proteins was completely absent in HSCs from IFNa receptor (IFNAR) knockout mice ( Figures 1D and S1E ). The analysis of forward, reverse, and 50:50 wild-type (WT):IFNAR À/À bone marrow chimeras revealed that type-I IFN signaling directly instructs Mk protein expression in phenotypic HSCs ( Figure S1H ). Canonical type-I IFN signaling results in the activation of the signal transducer STAT1 and crosstalk signaling to mTOR has been reported (Platanias, 2005) . Therefore, we investigated the involvement of STAT1 and mTOR in pI:Cmediated Mk protein upregulation. Either the pharmacological inhibition of mTOR using rapamycin or the genetic deletion of STAT1 reduced inflammation-mediated Mk protein upregulation, suggesting that both pathways participate in the regulation of Mk protein production in HSCs (Figures S1I-S1K). In contrast, stem cell antigen 1 (Sca-1), involved in pI:C-induced cell cycle activation of HSCs, was not required for pI:C-induced Mk protein expression ( Figure S1L ). Moreover, single administrations of lipopolysaccharide (LPS), mimicking a bacterial infection, or recombinant tumor necrosis factor alpha (TNFa), a cytokine involved in mediating acute inflammation, also triggered an increase of Mk proteins in HSCs comparable to pI:C ( Figure 1E ). In contrast to pI:C, LPS-mediated Mk protein expression in HSCs was mediated by TLR4/MYD88/TRIFsignaling ( Figure S1M ). Reducing platelet levels using a platelet depletion antibody without triggering inflammation induced only a minor increase of Mk proteins, further highlighting the importance of inflammatory signaling ( Figure S1N ). Together, these data demonstrate that inflammatory signaling associated with infections directly triggers Mk protein expression in phenotypic HSCs.
SL-MkPs within the Phenotypic HSC Compartment Increase Mk Protein Expression upon Acute Inflammation
Recent reports identified multipotent HSCs with intrisinc Mk bias as well as unipotent Mk-committed progenitors in the phenotypic HSC compartment (Sanjuan-Pla et al., 2013; Shin et al., 2014; Yamamoto et al., 2013) . To determine whether inflammation-driven Mk protein expression takes place primarily in multipotent HSCs or in other cell types present in the phenotypic HSCs compartment and to investigate whether elevated Mk protein levels are associated with Mk lineage fate decisions, we made use of high-throughput single-cell ex vivo lineage tracking (Figure 2A ). Single LT-HSCs were sorted into differentiation medium containing fluorescently labeled antibodies, and the morphology and expression of lineage makers of individual cells was tracked in clonally expanded progeny by daily fluorescence microscopy. This allowed a time-resolved analysis of ex vivo differentiation in a quantitative manner. As expected, the majority of HSCs from homeostatic mice formed large ''mixed'' colonies containing both myeloid and megakaryocytic cells. However, a fraction of the phenotypic HSCs generated exclusively mature Mks, suggesting that these cells were committed to S2A, and S2B) . This sets them apart from multipotent, but Mk-biased, populations such as Vwf + HSCs (Sanjuan-Pla et al., 2013) , but is in accordance with a recent single-cell transplantation study identifying Mk-committed progenitors with high selfrenewal potential in the HSC compartment (Yamamoto et al., 2013) . While some phenotypic HSCs directly gave rise to single Mks, others formed large colonies consisting of up to hundreds of mature Mks (Figures S2A and S2B) . These potent stem cell-like megakaryocyte-committed progenitors (SL-MkPs) are distinct to classical MkPs and exist within the phenotypic HSC pool during homeostasis ( Figures S2A and S2B ). The number of single-sorted HSCs giving rise to ''Mk only'' colonies during homeostasis and inflammation was the same (Figure 2B ), suggesting that commitment of multipotent HSCs to SL-MkPs occurs during homeostasis, and inflammatory signaling induces Mk protein expression without affecting lineage fate decisions. To determine which cell types increase Mk protein levels upon inflammation, we retrospectively assigned CD41 fluorescence intensity values (E) Flow cytometric analysis of CD41 and CD62P expression in HSCs 16 hr after pI:C, LPS and TNFa administration. In (A), (B), and (E), data are presented as mean ± SEM with n R 3. The significance was determined using an unpaired, two-tailed student's t test (*p % 0.05, **p % 0.01, ***p % 0.001, ****p % 0.0001, and non-significant: NS). See also Figure S1 .
from single-sorted HSCs to the colony types they formed (Figure 2C) . Phenotypic HSCs generating mixed colonies showed minor, but significant, increase in CD41 expression upon inflammation, whereas cells generating ''myeloid only'' colonies remained unaffected from CD41 upregulation. In contrast, SL-MkPs (i.e., cells giving rise to Mk only colonies) robustly increased CD41 expression to elevated levels upon inflammation, suggesting that SL-MkPs are the primary source of Mk protein expression upon pI:C treatment within the phenotypic HSC compartment.
To confirm this finding in vivo, we sub-fractionated LT-HSCs from ACTB-tdTomato mice based on their CD41 signal into CD41low and med for PBS treated mice and CD41low, med, and high for pI:C treated mice and traced the generation of tomato-positive lineage cells in the blood (Figures 2D and 2E ). In line with our single-cell ex vivo data, CD41low and CD41med HSCs from both PBS and pI:C treated mice showed multilineage reconstitution (Gekas and Graf, 2013) , whereas CD41high HSCs from pI:C treated mice exclusively generated platelets in a transient manner, demonstrating that these cells were committed to the Mk lineage ( Figure 2E ). In contrast, MkPs generated a much lower platelet chimerism, confirming that CD41high HSCs represent potent SL-MkPs that are superior to classical MkPs in their platelet generation capacity. Together, these data demonstrate that commitment of HSCs to SL-MkPs appears during homeostasis. While SL-MkPs express similar levels of Mk proteins compared to HSCs during homeostasis, inflammatory signaling triggers Mk protein expression in SL-MkPs without affecting lineage commitment of HSCs to SL-MkPs.
Inflammation Drives Functional and Cellular Maturation of SL-MkPs and MkPs
To investigate whether increased Mk protein expression might be attributed to an inflammation-driven maturation of SL-MkPs, we performed kinetic analyses of Mk generation ex vivo. While single-sorted control MkPs did not expand, form small Mk colonies, and mature within the first 2-3 days in culture, SL-MkPs (phenotypic HSCs generating Mk only colonies) from homeostatic mice expanded in an immature state until day 7-8, matured late, and formed large Mk colonies (Figures 3A, S2B, and S2C) . In contrast, SL-MkPs from pI:C treated mice generated mature Mks much faster ( Figures 3A and S2C For (C) and (E), the data are presented as mean ± SEM. The significance was determined using a Mann-Whitney-Wilcoxon test (*p % 0.05, **p % 0.01, ***p % 0.001, ****p % 0.0001, and non-significant: NS). See also Figure S2 . In (A), (E), (G), and (H), data are presented as mean ± SEM with n R 3. The significance was determined using a Mann-Whitney-Wilcoxon test (A and E), or an unpaired, two-tailed student's t test (G and H) (*p % 0.05, **p % 0.01, ***p % 0.001, ****p % 0.0001, and non-significant: NS). See also Figure S3 .
smaller overall size of Mk colonies ( Figure S2C ). Interestingly, CD41 expression of the colony-initiating SL-MkPs and MkPs was anti-correlative with both the expansion potency of the cell and with the time required to generate the first mature Mk ( Figure 3B ). Hence, the most primitive SL-MkPs with low Mk protein expression generate the largest Mk colonies at late time points, while cells with high Mk protein expression generate smaller Mk colonies at early time points. In contrast to SL-MkPs, inflammation had no impact on Mk maturation time or the overall amount of mature Mks generated from HSCs with mixed colony potential ( Figure S2C ). Alpha granules or their precursors in the form of multivesicular bodies (MVBs) are typical features of megakaryocytic maturation (Heijnen et al., 1998) . Comparison of Mk proteins that were synthesized upon inflammation in HSCs with the platelet alpha-granule proteome (Browne et al., 2001) revealed that the majority of these proteins are typically localized to alpha granules ( Figure 3C ). In accordance with this, electron microscopy and immunofluorescence microscopy of purified HSCs revealed the generation of MVB-like structures 16 hr after induction of inflammation, which was correlated with the upregulation of Mk proteins and was a particularly frequent event in CD41 high SL-MkPs ( Figures 3D, 3E , and S3A-S3C). Electron microscopy and FACS analysis revealed an IFNAR-STAT1 and mTOR dependent cell size increase of HSCs, which was particularly attributed to SL-MkPs that upregulate Mk proteins ( Figures 3F, S3D , and S3E).
Polyploidy is a characteristic feature of terminally maturated Mks (Machlus and Italiano, 2013). A strong increase in the number of polyploid Mks was observed 16 hr after pI:C treatment ( Figure 3G ). Quantifying ploidy levels in stem and progenitor cell populations revealed that, in particular, MkPs were driven into endomitosis in an IFNAR-STAT1 dependent manner, whereas phenotypic LT-HSCs did not enter endomitosis (Figures 3H and S3F) . Together, these data suggest that inflammation drives a rapid and efficient cellular maturation program of both SLMkPs and MkPs. SL-MkPs are maintained in a highly potent and primitive state during homeostasis, but are efficiently pushed toward maturation upon inflammation, adapting an intermediate state between homeostatic SL-MkPs and classical MkPs. In contrast to classical MkPs, which are driven into endomitosis forming mature Mks, SL-MkPs are pushed toward maturation without directly undergoing endomitosis, thereby maintaining their high proliferative expansion capacity.
Inflammation-Driven Upregulation of Megakaryocytic Proteins in Phenotypic HSCs Is Mediated by a Post-Transcriptional Mechanism
To determine whether the increase in Mk proteins is transcriptionally controlled, we compared transcript and protein levels of HSCs 16 hr after induction of inflammation. As expected, IFN response genes were regulated at the transcriptional level with a high induction of transcripts, resulting in enhanced protein production ( Figures 4A, 4B , and S4A) (Platanias, 2005) . In contrast, Mk genes remained unchanged or were even downregulated at the transcriptional level, while the corresponding proteins were significantly increased ( Figures 4A, 4B , (E) Ribosomal profiling of Mk transcripts upon inflammation. The mRNA levels of housekeeping (Sdha) and Mk genes (others) were measured in both fractions and normalized to Actb. In (C)-(E), data are presented as mean ± SEM with n R 3. The significance was determined using an unpaired, two-tailed student's t test (*p % 0.05, **p % 0.01, ***p % 0.001, ****p % 0.0001, and non-significant: NS). See also Figure S4 . Figure S4B ). Since most Mk transcripts were detected at high levels in HSCs, we reasoned that inflammation-mediated Mk protein production might be a result of increased translation of transcripts that are already present during homeostasis. To measure global levels of translation in phenotypic HSCs, we made use of an O-propargyl-puromycin (OP-Puro)-based method, which facilitates the measurement of translational rates on single-cell level in vivo (Liu et al., 2012; Signer et al., 2014) . In accordance with a recent study, homeostatic HSCs showed very low levels of translational activity (Signer et al., 2014) , but had significantly increased translational rates upon pI:C treatment (Figure 4D) . Importantly, increased translational activity correlated with enhanced Mk protein expression ( Figure S4C ). In accordance with an enhanced translational activity, phenotypic HSCs demonstrated reduced levels of the translation inhibitors Pdcd4 and Eef2k upon pI:C treatment, which negatively regulate the translation initiation and elongation factors Eif4a and Eef2 (Dorrello et al., 2006; Kruiswijk et al., 2012 ) ( Figure S4D ). Occupancy of transcripts at ribosomes is a strong indication of translational activity (Ingolia et al., 2012) . Accordingly, Mk transcript occupancy at ribosomes significantly increased upon induction of inflammation, suggesting enhanced translation of these transcripts (Figures 4E and S4E) . Together, these experiments suggest that even though most Mk transcripts are expressed in phenotypic HSCs, translation of these transcripts is repressed during homeostasis. In contrast, pI:C treatment instructs efficient translation, resulting in an enhanced Mk protein production.
SL-MkP Commitment Is Associated with a Coordinated Mk Transcription Program Providing Transcriptional
Templates for Inflammation-Driven Protein Synthesis Even though high expression of Mk transcripts in phenotypic HSCs has been well documented (Gekas and Graf, 2013; Må nsson et al., 2007; Sanjuan-Pla et al., 2013) , the mechanistic role of transcriptional priming is poorly understood. Our data suggest that Mk transcripts are expressed during homeostasis and serve as a template for an efficient inflammation-induced emergency Mk protein synthesis program in SL-MkPs. According to this model, high expression of Mk transcripts in SL-MkPs would be required for mounting an efficient inflammation-mediated post-transcriptional increase in Mk proteins, whereas low Mk transcriptional priming in HSCs would explain their attenuated response.
To characterize Mk lineage priming in HSCs, SL-MkPs, and classical MkPs, we measured Mk and control transcripts of individual MkPs and CD41 sub-populations of LT-HSCs from PBS and pI:C treated mice by single-cell quantitative (q)PCR. In accordance with a previous report, all investigated Mk transcripts were expressed in a bimodal fashion in HSCs, with Cycle-threshold differences (DCt) of 15-20 between high-expressing cells and low-expressing cells, suggesting that Mk transcripts are expressed in an ''ON'' or ''OFF'' state ( Figure 5A ) (Guo et al., 2013) . Heatmap representation and principal component analysis (PCA) of this data revealed that all MkPs expressed Mk transcripts to high homogenous levels, whereas most LTHSCs with homeostatic CD41 levels (CD41low/med HSCs) expressed a unique combination of Mk transcripts in the ON or OFF state. This was reflected in a funnel-shaped cloud, with each cell occupying a unique location in our PCA analysis, suggesting a stochastic Mk transcript expression (Figures 5B and 5C) . Interestingly, some homeostatic LT-HSCs clustered together at the tip of the funnel, representing cells with a coordinated Mk transcription profile with all Mk transcripts in the ON state. Of note, almost all CD41high HSCs from pI:C treated mice (i.e., SL-MkPs) expressed all Mk transcripts in the ON state and clustered together with these cells at the tip of the funnel ( Figures 5B-5D ), demonstrating that homeostatic SL-MkPs exhibit a coordinated Mk transcription profile and efficiently upregulate Mk protein synthesis upon inflammation. The hypothesis that commitment of HSCs to SL-MkPs is associated with a switch from a stochastic toward a coordinated Mk transcription program was further supported by a significant drop in the Fano factor, an indicator for a system's stochasticity and transcriptional noise ( Figure S5A ) (Munsky et al., 2012; Ozbudak et al., 2002) .
Profiling of transcription factors (TFs) in single HSCs revealed that expression of many known Mk TFs correlated with Mkcommitment (e.g., highest expression in classical MkPs and SL-MkPs) and expression of Mk lineage transcripts ( Figures  S5B-S5D ). This suggests that Mk transcriptional priming and Mk lineage commitment of SL-MkPs are established by transcriptional regulators during homeostasis, while inflammation drives a post-transcriptional Mk protein synthesis from these pre-existing transcripts.
To investigate how closely related multipotent HSCs and SLMkPs are, we performed global gene expression analysis of single HSCs and Lin The most potent HSCs are maintained in a long-term quiescent (dormant) state where they serve as a reserve pool for conditions of acute stress (Wilson et al., 2008) . Long-term quiescent, labelretaining cells (LRCs) can be identified in the HSC compartment using doxycyclin (dox) treatment of SCL-tTA:H2B-GFP mice (Wilson et al., 2008) . Whether dormant lineage-restricted progenitors exist in the phenotypic HSC compartment is unknown. Interestingly, an inflammation-mediated increase in Mk protein expression, cell size, and granularity could be observed both in non-LRC LT-HSCs and in dormant LRC LT-HSCs, suggesting that SL-MkPs also exist in a dormant state ( Figures 6A-6C , S6A, and S6B). Accordingly, single-cell ex vivo lineage tracking showed that SL-MkPs exclusively generating mature Mks could be found both in the non-LRC fraction and in the dormant LRC fraction of the LT-HSC compartment. Interestingly, dormant SL-MkPs formed larger Mk-colonies and required a longer time to generate the first mature Mks when compared to their non-LRC counterparts ( Figure 6D ). This suggests that the most primitive and most potent SL-MkPs reside in a dormant state and, hence, do not contribute to steady-state megakaryopoiesis.
To investigate whether quiescent SL-MkPs are activated upon inflammation, we measured cell cycle activity in HSC CD41 subpopulations. Ki67-Hoechst and BrdU incorporation assays revealed a rapid and efficient cell cycle entry of SL-MkPs that increased Mk protein levels 16 hr post pI:C treatment, whereas the remaining HSC pool was activated at later time points . Accordingly, inflammation triggered by LPS or TNFa injection resulted in a similar cell cycle induction of these SL-MkPs that increased Mk protein levels ( Figure S6C ), demonstrating that distinct inflammatory signals efficiently activate quiescent SL-MkPs.
FoxO3a is a key TF that instructs transcription of the cell cycle inhibitors p27, p57, p107, and p130, thereby maintaining HSCs in a quiescent state (Miyamoto et al., 2007; Tothova and Gilliland, 2007) . Cell cycle entry of HSCs is frequently associated with FoxO3a phosphorylation and subsequent exclusion from the nucleus (Tothova and Gilliland, 2007) . In phenotypic HSCs from control mice and HSCs from pI:C treated mice with homeostatic CD41 expression, FoxO3a was localized mainly to the nucleus. In contrast, in CD41high HSCs (i.e., SL-MkPs) from pI:C treated mice, FoxO3a was frequently redirected to the cytoplasm, suggesting that FoxO3a inactivation is associated with inflammation-induced cell cycle entry of SL-MkPs ( Figures 6H and S6D) . In accordance, a significant decrease in expression of FoxO3a targets p27, p57, p107, and p130 was specifically observed in SL-MkPs that increased Mk proteins, whereas p19, which is not a FoxO3a target, remained unchanged ( Figure 6I ). Together, these data suggest that acute inflammation triggers FoxO3a inactivation and efficient cell cycle activation of quiescent SL-MkPs.
Repeated Cycles of Type-I IFN Mediated Inflammation Trigger the Exhaustion of SL-MkPs and Other Megakaryocytic Progenitors
We have shown that a single induction of inflammation drives maturation of SL-MkPs and MkPs. Accordingly, repeated cycles of inflammation over a long time period would be anticipated to result in an exhaustion of these cell types. To investigate this hypothesis, mice were treated with pI:C every 3 days for a time period of 30 days (ten doses) ( Figure 7A ). While a single pI:C dose resulted in an augmented Mk protein production in HSCs and MkPs, as well as in an increase in mature polyploid Mks as described above, inflammation-mediated Mk protein production and the number of MkPs and mature polyploid Mks was significantly reduced upon repeated doses of pI:C ( Figures 7B-7D ). Regeneration from platelet consumption after single pI:C treatment was accomplished within 7 days, whereas after ten doses, the hematopoietic system required longer to rebuild the platelet pool, reflecting the reduction in MkPs and SL-MkPs (Figure 7E ). These data indicate that repeated cycles of pI:C-mediated inflammation can result in a transient exhaustion of MkPs and SL-MkPs due to a constant drive toward maturation, which prevents an efficient platelet recovery after inflammation-mediated platelet loss.
DISCUSSION
During infection, platelets actively counteract infectious agents by releasing immunomodulatory agents and interacting with neutrophils to trap pathogens (Jenne et al., 2013; Yeaman, 2014) , thereby, being rapidly consumed. Since low platelet levels during inflammation are associated with loss of vascular integrity and septic shock (Goerge et al., 2008; Xiang et al., 2013) , a rapid recovery of platelet levels is of fundamental importance. We show that inflammatory signaling instructs a rapid Mk maturation program at distinct levels of megakaryopoiesis to regenerate the lost platelet pool. While MkPs are efficiently driven into endomitosis, leading to a strong increase in mature Mks, a small pool of potent Mk-committed progenitors (SL-MkPs) within the phenotypic HSC compartment replaces the lost MkPs. Even though SL-MkPs and classical MkPs appear to be closely related in their lineage potential and their coordinated Mk transcription profile, SL-MkPs share many features with HSCs which set them apart from MkPs. Similar to HSCs, and in contrast to MkPs, SL-MkPs are small in cell size, suppress Mk protein production, and are mainly quiescent. Due to their quiescent, partly dormant nature, SL-MkPs contribute little to steady-state megakaryopoiesis, but serve as an emergency pool for inflammatory insult.
As a result of their quiescence and the suppression of Mk protein production, SL-MkPs are maintained in a metabolically inactive, but primed, state, allowing them to be readily activated. Inflammatory signaling triggers FoxO3a inactivation, resulting in cell cycle activation of quiescent SL-MkP. Moreover, inflammation-mediated maturation of SL-MkPs is associated with mTOR and STAT1 dependent increase in cell size, enhanced Mk protein production, and appearance of alpha granular precursors. In line with our findings, both mTOR and STAT1 signaling have been previously implicated in megakaryopoiesis (Huang et al., 2007; Raslova et al., 2006) .
During homeostasis, post-transcriptional regulation of gene expression is a rare event in HSCs and changes in protein and mRNA levels are highly correlated during commitment (Cabezas-Wallscheid et al., 2014) . In contrast to homeostasis, our findings reveal the presence of significant post-transcriptional regulation in response to acute inflammation. Our data suggest that Mk transcripts are expressed, but that translation is repressed during homeostasis, resulting in low Mk protein production, whereas inflammatory signaling drives efficient translation of these transcripts, revealing an important role for Mk lineage priming during emergency megakaryopoiesis. This model is supported by recent findings demonstrating that HSCs suppress protein synthesis during homeostasis (Signer et al., 2014) . Our single-cell gene expression data provide novel insights into the basis of Mk lineage priming and suggest that multipotent HSCs and SL-MkPs exhibit highly related transcriptomes, but switch from a stochastic to a coordinated Mk In this study, we make use of CD41 expression to discriminate SL-MkPs during inflammation. During homeostasis, CD41 is expressed at low levels by HSCs and other myeloid progenitors (Gekas and Graf, 2013; Yamamoto et al., 2013) . Due to an intrinsic repression of Mk protein synthesis, SL-MkPs express CD41 to similar levels as HSCs during homeostasis, but efficiently induce CD41 expression upon inflammatory signaling.
This suggests that high expression of CD41 is a marker for Mk commitment, while CD41 has broader roles in hematopoiesis as highlighted by the fact that CD41 À/À mice display multilineage hematopoietic defects (Gekas and Graf, 2013) . A recent study reported an increased CD41 expression in HSCs upon aging (Gekas and Graf, 2013) . Accordingly, also the expression of other Mk proteins such as CD62P and Vwf increased in the phenotypic HSC compartment upon aging, and treatment of aged mice with pI:C triggered Mk protein synthesis to even higher levels (data not shown). These data are in line with a potential expansion or enhanced maturation of SL-MkPs during aging. While acute inflammatory signaling drives rapid maturation of MkPs, resulting in increased platelet production, repeated cycles of type-I IFN-mediated inflammation can trigger a constant push of maturation and thus a partial exhaustion of MkPs. These findings reveal that depending on the context and timing, the same inflammatory stimuli can be associated with opposing effects on megakaryopoiesis. This sheds light on the question of why some inflammatory states and diseases are associated with thrombocytosis, whereas others provoke thrombocytopenia In (B), (D), and (E), data are presented as mean ± SEM with n R 3. The significance was determined using an unpaired, two-tailed student's t test (*p % 0.05, **p % 0.01, ***p % 0.001, ****p % 0.0001, and non-significant: NS). (Cole et al., 1998; Kawamoto, 2003; Martin and Shuman, 1998; Rajan et al., 2005) .
EXPERIMENTAL PROCEDURES In Vivo Treatments
To induce an inflammation, mice were injected intraperitoneal with a single dose of 5 mg/kg pI:C (Invitrogen), 0.25 mg/kg LPS (Sigma), or 0.75 mg/kg recombinant TNFa (PeproTech). Alternatively, mice were treated every third day for 30 days with 5 mg/kg pI:C. Platelet depletion was performed by intravenous injection of 2 mg/kg rat monoclonal antibody directed against mouse GPIb (Emfret Analytics). For transient mTOR blockage, mice were pretreated with 1.5 mg/kg rapamycin 2 hr prior to pI:C treatment. 
Transplantation Experiments
Quantitative Proteomics
Proteomic analysis was performed as described previously (Cabezas-Wallscheid et al., 2014), with minor differences.
H2B-GFP Label-Retention Assays
In vivo label-retention assays using SCL-tTA:H2B-GFP mice were performed as previously described (Wilson et al., 2008) . SCL-tTA:H2B-GFP mice were maintained on water containing 2 mg/ml doxycyline hydrate (Sigma) in 5% glucose for a 60 day chase period.
Single-Cell qPCR and Single-Cell RNA-Seq Single cells were directly sorted into PCR-tubes loaded with lysis buffer using a BD FACSAria II (BD Bioscience) under the single-cell mode. Single-cell qPCR was essentially performed as previously described (Guo et al., 2013) , with minor differences. Single-cell RNA-seq was performed according to a modified version of the QUARTZ-Seq protocol (Sasagawa et al., 2013) .
Single-Cell Ex Vivo Lineage Tracking
Single-cell ex vivo lineage tracking was performed according to a modified version of the approach described by Eilken et al. (2009) .
Electron Microscopy
Transmission electron microscopy was performed as described previously (Platani et al., 2009) , with minor differences.
ACCESSION NUMBERS
The proteomics data have been deposited to ProteomeXchange Consortium and are accessible at http://www.ebi.ac.uk/pride with the dataset identifier: PXD001500. The single-cell RNA-seq data can be accessed under Gene Expression Omnibus under accession number GSE64002. Significance was determined using an unpaired, two-tailed student's t test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, NS: non-significant Single-cell qPCR data was binned into clusters with cells positive and negative for Vwf and compared to CD41high SL-MkPs of pI:C treated mice.
SUPPLEMENTAL INFORMATION
Significance was determined using a paired two-tailed student's t test (A). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, NS: non-significant. Significance was determined using an unpaired, two-tailed student's t test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, NS: non-significant (Ermolaeva et al., 2008) (provided by M. Pasparakis), ACTB-dtTomato (Muzumdar et al., 2007) and SCL-tTA:H2B-GFP (Wilson et al., 2008 ) mice have been previously described.
SUPPLEMENTAL TABLE LEGENDS
Bone Marrow Preparation and Lineage Depletion
Bone marrow was prepared from femur, tibia, humerus, ilium, and columna vertebralis by crushing bones in RPMI-1640 medium (Sigma) supplemented with 2% FCS. For cell sorting, cells expressing the lineage markers CD11b (M1/70), Gr-1 (RB6.8C5), CD4 (GK1.5), CD8a (53.6.7), Ter119 (Ter119) and B220 (RA3-6B2) were depleted by incubation with rat monoclonal antibodies. Subsequently, cells were washed and incubated with anti-rat IgGcoated Dynabeads for 15 min (4,5µm supermagnetic polystyrene beads (Invitrogen), 1mL of beads / 3x10 8 bone marrow cells). Cells expressing lineage markers were depleted using magnetic separation and the remaining lineage-negative cells were isolated.
Flow Cytometry and Cell Sorting
For flow cytometric analysis, bone marrow (BM) was prepared, cells were incubated with respective FACS-antibody mixes in RPMI-1640 supplemented with 2% FCS and stained for 30 min on ice. For Phospho-flow experiments, BM cells were stained with surface markers, and fixed, permeabilized and stained using Phosflow Perm Buffer I and III (BD Biosciences) according to manufacturer's instructions. Cells were analyzed using LSRII and LSRFortessa flow cytometers equipped with 350nm, 405nm, 488nm, 561nm, and 640nm lasers (both BD biosciences). Data was analyzed using FlowJo (TreeStar). For FACS-sorting FACSAria I, II and III cell sorters (BD Biosciences) were used.
FACS Gating Strategy / Gating Without Sca-1
To compare populations between homeostasis and inflammation, populations were gated without stem cell antigen 1 (Sca-1), as it is highly up-regulated during inflammation. Gating Figure S1A and S1B), whereas committed progenitors were Sca-1-negative ( Figure S1C ).
Cell Cycle Analysis
For Ki67-Hoechst cell cycle and ploidy analysis, surface stainings were performed as described. Subsequently, cells were fixed and permeabilized using cytofix-cytoperm buffer (BD Biosciences) and incubated with Ki67 antibody (BD Biosciences) overnight at 4°C. Cells were stained with 25µg/mL Hoechst 33342 (Invitrogen) and analyzed.
For BrdU incorporation assays, mice were injected i.p. with 18mg/kg BrdU (Sigma), 12h
prior to the experiment. BM was isolated as described and stained for surface markers.
Subsequently, cells were fixed and BrdU staining was performed according to instructions of the BrdU Flow kit (BD Biosciences).
Measurement of the translational activity using OP-Puro
Measurement of the translational activity using O-propargyl-puromycin (OP-Puro) was performed as described before with minor differences (Signer et al., 2014) . 14.5h after PBS or pI:C administration, mice were treated intraperitoneal with 50mg/kg OP-Puro. Bone marrow was harvested 16h after PBS/pI:C and1.5h after OP-Puro administration. Subsequently, cells 
Bone Sections
8µm bone sections of frozen femurs were prepared using the Kawamoto tape method (Kawamoto, 2003) with minor differences. Briefly: Bones were excised from mice, fixed, decalcified and placed in sucrose prior to embedding in OCT and freezing. 8µm sections of frozen femurs were then cut using the Leica tape system, stained with indicated antibodies overnight at 4°C and images were acquired using an LSM710 microscope. Images were prepared using ImageJ software.
Single-Cell RNA sequencing
For amplification of cDNA and construction of libraries for paired-end sequencing, a slightly modified version of the QUARTZ-Seq protocol (Sasagawa et al., 2013) Musculus genome (assembly GRCm38) to which the sequences of the ERCC spike-ins had been appended. HTSeq (Simon Anders et al., in revision) was used to obtain transcript count tables, which were further analyzed using R. In particular, we employed a published computational method to identify genes whose observed expression variability exceeds the variability caused by technical noise (Brennecke et al., 2013) . Technical noise of the method was estimated by relying on the known concentration of ERCC control RNAs spiked into the reaction at the initial step. Principal component analysis (PCA) was used to cluster cells based on global patterns of gene expression. Typically, PCA is preceded by scaling of the individual variables to unit variance in order to avoid that variables measured on different scales affect the eigenvector decomposition differently. Here, however, such scaling would give equal weight to genes whose observed variance is mostly due to technical noise and to genes whose observed variance is predominantly biological. We therefore scale the read count n of gene j in cell i by where L is the number of cells, µ j is the mean read count of gene j and v(µ j ) is the expected technical variance of a gene with expression µ j , as defined by Brennecke et al.
Single-Cell qPCR
Single cells were sorted using a BD FACSAria II (BD Bioscience) under the single-cell mode. Cells were deposited directly into PCR-tubes loaded with 5µL RT/Taq-PCR master mix (1xCellsDirect reaction mix, Invitrogen; 0.1µM primer pool and 0.1µL RT/Taq enzyme mix, Invitrogen). Samples were immediately transferred to a PCR-machine. Sequencespecific reverse transcription (60 min, 50°C) was followed by reverse transcriptase inactivation / Taq polymerase activation (3min, 95°C), and 23 cycles of cDNA preamplification (15s 95°C, 15s 60°C, final elongation 15min 60°C). Pre-amplified samples were diluted 10-fold and 1µL was used for qPCR analysis utilizing Power SYBR® Green reagent (Applied Biosystems) on a ViiA™ 7 Real-Time PCR system (Applied Biosystems).
Ex-Vivo Single-cell Lineage Tracing
Bone marrow was prepared, lineage-depleted and stained with FACS antibodies from mice 16 h after treatment with PBS or pI:C, as described above. Single cells were sorted into round bottom 96-well plates using a BD FACSAria III (BD Bioscience) under the single-cell mode into 10µL StemPRO34 (Sigma) supplemented with 10% pre-tested FCS, 100ng/mL mSCF, 100ng/mL mTPO, 10ng/mL mIL-3, 2U/mL hEPO, 2mM L-Gln, 50µM 2-me and 1% P/S.
Cells were transferred into 1536-well plates, cultured for 14 days at 37°C and 5% CO2, and imaged daily using an AxioObserver Z1 (Zeiss) equipped with Spextra X fluorescence light source (Lumencor), motorized stage, Definitive Focus, Axiocam HRm, 0,4x TV adapter, 10x
FLUAR objective and single band pass filterset optimized for detection of Alexa-647 and PE.
Culturing media was supplemented with 20ng/mL CD41-PE (BD Bioscience, 558040) and 100ng/mL custom labeled fractions resolved were acidified and desalted with C 18 Stagetips (Empore 3M) (Rappsilber et al., 2007) . Peptide samples were dried by vacuum centrifugation and stored at -20ºC until further use.
LC-ESI-MS/MS analysis.
In technical duplicates, peptides were separated using the nanoACQUITY UltraPerformance LC system (Waters) fitted with a trapping column (nanoAcquity Symmetry C 18 , 5µm particle size, 180 µm inner diameter x 20 mm length) and an analytical column (nanoAcquity BEH C 18 , 1.7µm particle size, 75µm inner diameter x 200 mm length). The outlet of the analytical column was coupled directly to an Orbitrap Velos Pro was used, and the fragmentation was performed after accumulation of 3 x 10 4 ions or after filling time of 100 ms for each precursor ion (whichever occurred first). MS/MS data was acquired in centroid mode. Only multiply charged (2+ and 3+) precursor ions were selected for MS/MS. The dynamic exclusion list was restricted to 500 entries with maximum retention period of 30 s and relative mass window of 7 ppm. In order to improve the mass accuracy, a lock mass correction using a background ion (m/z 445.12003) was applied. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (Vizcaino et al., 2014) via the PRIDE partner repository with the dataset identifier PXD001500.
Protein identification and quantification. MS raw data files were processed with MaxQuant (version 1.2.2.5) (Cox and Mann, 2008) . Enzyme specificity was set to trypsin/P and a maximum of two missed cleavages were allowed. Cysteine carbamidomethylation and methionine oxidation were selected as fixed and variable modifications, respectively.
Methionine oxidation and protein N-terminal acetylation were selected as variable modifications. The derived peak list was searched using the built-in Andromeda search engine (version 1.2.2.5) in MaxQuant against the Uniprot mouse database (2011.06.21) containing 53,623 proteins to which 248 frequently observed contaminants as well as reversed sequences of all entries had been added. Initial maximal allowed mass tolerance was set to 20 ppm for peptide masses, followed by 6 ppm in the main search, and 0.5 Dalton for fragment ion masses. The minimum peptide length was set to six amino acid residues and three labeled amino acid residues were allowed. A 1% false discovery rate (FDR) was required at both the protein level and the peptide level. In addition to the FDR threshold, proteins were considered identified if they had at least one unique peptide. The protein identification was reported as an indistinguishable "protein group" if no unique peptide sequence to a single database entry was identified. The 'match between runs' was enabled for consecutive peptide fractions with a 2 min time window. The iBAQ algorithm was used for estimation of the abundance of different proteins within a single sample (proteome) (Schwanhausser et al., 2011) .
Proteomic bioinformatic analysis. For evaluation of differential protein expression between
PBS and pI:C, statistical analysis was performed for the proteins quantified in at least two replicates using the Limma package in R/Bioconductor (Gentleman et al., 2004; Smyth, 2004) . After fitting a linear model to the data, an empirical Bayes moderated t-test was used for the protein ratios. P-values were then adjusted for multiple testing with Benjamini and Hochberg's method and proteins with an adjusted p-value lower than 0.05 were considered to be differentially expressed between PBS and pI:C. Protein classification was performed using PANTHER classification system (Mi et al., 2007) . Network analysis was done using STRING database (Jensen et al., 2009) . Network visualization was performed in Cytoscape v2.8.3 (Shannon et al., 2003) . For proteins with an adjusted p-value lower than 0.05, Gene Ontology (GO) enrichment analysis was performed using the functional annotation tool of DAVID (Huang et al., 2009) . ggplot2 was used for visualization of results (Wickham et al. 2009 ). The interferon response cluster was determined by extracting the overlap of the significantly changed proteins (p adj < 0.05) of the HSC samples and the interferon response gene sets (Bosco et al., 2010; Browne et al., 2001) . The megakaryocyte and platelet cluster was determined by calculating the overlap of the significantly changed proteins with highly expressed proteins (more than 4000 estimated copy numbers) of the platelet proteome (Burkhart el al., 2012) and with proteins of the platelet alpha granule proteome (Maynard et al., 2010) .
Measuring Ribosome-Associated Transcript Abundance
The ribosome profiling approach was adapted and modified from Ingolia et al. (2012) using qPCR as a readout for transcript abundance. 1x10 7 lineage-depleted bone marrow cells were lysed in 300µL ice-cold lysis buffer (1% (vol/vol) Triton X-100, 25U/ml, Turbo DNase I (Ambion), 20mM Tris·Cl (pH 7.5), 150mM NaCl, 5mM MgCl 2 , 1mM DTT and 100µg/mL cycloheximide), incubated for 10 min on ice and triturated 10 times through a 26-G needle.
The lysate was centrifugated for 10 min at 20.000g. The supernatant was underlayed with 700µL of 1M sucrose (in 20 mM Tris·Cl (pH 7.5), 150mM NaCl, 5mM MgCl 2 , 1mM DTT and 100µg/ml cycloheximide, 20U/ml SUPERase·In RNase Inhibitor (Life Technologies)) and applied to ultracentrifugation using a TLS-55 rotor (Beckman Coulter) at 55.000 rpm at 4°C for 4h. RNA was extracted from the ribosomal pellet and from the cytosolic fraction by resuspension in 700µl Qiazol reagent (Qiagen), followed by incubation for 5 min on ice, vortexing for 5 min, and a second incubation for 5 min at 25°C. The RNA was extracted by adding chloroform and phase separation, followed by purification using the miRNAeasy kit (Qiagen) according to manufacturer's instructions. Transcripts were reverse transcribed by gene-specific reverse transcription using the SuperScript Vilo kit (Invitrogen) according to manufacturer's instructions. Relative transcript abundance of the ribosomal and cytosolic fraction was determined by qPCR analysis of genes of interest and normalization to house keeping genes.
Electron Microscopy
Transmission electron microscopy was performed as described previously (Platani et al., 2009 
Statistics
If not indicated otherwise statistical analyses were performed using an unpaired, two-tailed student's t test or a Mann-Whitney-Wilcoxon test and results are presented as mean ± SEM with n ≥ 3. For proteomics and single-cell RNAseq analysis p-values were adjusted for multiple testing using the Benjamini and Hochberg's method.
Data Analyses and Visualization
Gene expression data were analyzed and visualized using R packages (scatterplot3d, beanplot, FactoMineR, VennDiagram and custom-made scripts) and Prism. Heatmaps were generated using Multiple Experiment Viewer. Flow cytometry data were analyzed using FlowJo. Gene set enrichment analyses (GSEA) were performed and visualized using broad GSEA-software (Subramanian et al., 2005) . For heatmap representation and GSEA of singlecell RNAseq data, the Mk and platelet cluster was defined as described above, except that the adjusted p-value of differential expressed proteins was increased to 0.1 to identify upregulated proteins upon pI:C treatment. Gene Ontology (GO) analysis was performed using the functional annotation tool of DAVID (Huang et al., 2009 ).
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